DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amerge (Naratriptan) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Amerge (Naratriptan) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Amerge side effects in female

Reported by a consumer/non-health professional from France on 2012-05-24

Patient: female

Reactions: Disseminated Intravascular Coagulation, Hepatic Failure, Lactic Acidosis, Gastrointestinal Necrosis, Multi-Organ Failure, Overdose, C-Reactive Protein Increased, Dialysis, Drug Administration Error, Candidiasis, White Blood Cell Count Increased, Intestinal Ischaemia, Neutrophil Count Increased, Intestinal Obstruction, Toxicity To Various Agents, Ascites, Anxiety, Volvulus, Renal Failure, Faecal Vomiting, Septic Shock, Abdominal Adhesions

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Grapefruit Juice (Formulation Unknown) (Grapfruit Juice)
    Dosage: see dosage text / oral
    Administration route: Oral

Amerge
    Dosage: 1 tablet / six times per day / oral
    Administration route: Oral
    Indication: Migraine
    Start date: 2011-04-21
    End date: 2011-04-21

Other drugs received by patient: Levothyroxine Sodium; Ibuprofen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017